Trials / Completed
CompletedNCT02447133
TopQ Cut-off Score Validation Study for 3D OCT-1 Maestro
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 12 (actual)
- Sponsor
- Topcon Medical Systems, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to validate the TopQ cutoff scores, which have been previously determined.
Detailed description
Scans with a TopQ score below the optimum cut-off should be considered to be poor or unacceptable quality, and scans with a TopQ score above the cut-off should be considered good or acceptable quality. The study will evaluate the predetermined cut-off values by investigating measurement variability of scans.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | 3D OCT-1 Maestro | OCT Machine used for diagnostic purposes |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2015-05-01
- Completion
- 2015-05-01
- First posted
- 2015-05-18
- Last updated
- 2022-06-29
- Results posted
- 2017-01-31
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02447133. Inclusion in this directory is not an endorsement.